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Massachusetts Institute of Technology, Cambridge, MassachusettsABSTRACT Cellular physical properties are important indicators of specific cell states. Although changes in individual bio-
physical parameters, such as cell size, density, and deformability, during cellular processes have been investigated in great
detail, relatively little is known about how they are related. Here, we use a suspendedmicrochannel resonator (SMR) to measure
single-cell density, volume, and passage time through a narrow constriction of populations of cells subjected to a variety of
environmental stresses. Osmotic stress significantly affects density and volume, as previously shown. In contrast to density
and volume, the effect of an osmotic challenge on passage time is relatively small. Deformability, as determined by comparing
passage times for cells with similar volume, exhibits a strong dependence on osmolarity, indicating that passage time alone does
not always provide a meaningful proxy for deformability. Finally, we find that protein synthesis inhibition, cell-cycle arrest, protein
kinase inhibition, and cytoskeletal disruption result in unexpected relationships among deformability, density, and volume. Taken
together, our results suggest that by measuringmultiple biophysical parameters, one can detect unique characteristics that more
specifically reflect cellular behaviors.INTRODUCTIONCellular biophysical properties reflect aggregate effects
of particular cellular activities, such as malignant trans-
formation, differentiation, cell-cycle progression, disease
response, and apoptosis. Studying these properties can
help provide insight into the underlying molecular mecha-
nisms that govern cellular behavior. For example, an in-
crease in the metastatic potential of cancer cells has been
correlated with increased cell deformability (1–6). Studies
on differentiation have also reported that deformability
decreases as stem cells become more differentiated (7,8).
The cell-cycle stage is known to be associated with changes
in cell shape and deformability (9,10). Red blood cells
(RBCs) affected by malaria show decreased deformability
and density (11,12). Finally, previous studies have reported
that apoptosis is related to volume shrinkage and changes in
cell deformability (13,14).
Another common physiological source of changes in
cellular biophysical properties is shifts in extracellular
osmolarity. Certain tissues, such as the kidney, are regu-
larly exposed to dramatic osmolarity shifts and adjust their
membrane surface area to allow for increases or decreases
in cell volume to maintain a constant cortical tension (15).
Articular cartilage in synovial joints, such as the knee and
hip, is subjected to both static and dynamic mechanicalSubmitted February 18, 2015, and accepted for publication August 24,
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0006-3495/15/10/1565/9compression during articulation, resulting in changes
in the interstitial osmolarity of the cartilage tissue (16).
This in turn can affect the biosynthesis rate, deformability,
and volume of chondrocytes in the tissue (17–19). More-
over, the inability to respond to an osmotic challenge
can result in impaired function, as is the case with T lym-
phocytes lacking the osmosensitive transcription factor
NFAT5/TonEBP. Eliminating NFAT5/TonEBP expression
prevents normal cell proliferation and development of
adaptive immunity, likely due to an inability to adapt to
the hyperosmolar conditions present in many lymphoid tis-
sues (20).
Although most studies have focused on the measurement
of individual biophysical parameters, increasing evidence
shows that combining information from measurements
of multiple parameters can improve prediction of cell state.
RBCs from patients with thalassemia, a genetic disorder that
leads to a measurable but not significant decrease in RBC
volume, can be distinguished from healthy RBCs based on
a simultaneous comparison of both mass and density, but
not on either parameter individually (12). One can accu-
rately predict the differentiation potential of stem cells by
measuring the deformability of stem cells along with size,
but not by measuring size alone (21,22). By measuring de-
formability and diameter, one can also identify four types of
malignant diseases from a pleural effusion, whereas such an
identification based on a single parameter leads to an incom-
plete prediction of disease state (8). Measurements of the
deformability and friction of cancer cells have revealed
that reduced friction may play a role in further facilitatinghttp://dx.doi.org/10.1016/j.bpj.2015.08.038
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1566 Byun et al.the passage of more deformable metastatic cancer cells
through tight spaces (23).
Here, we used a murine pro-B cell line as a model system
and measured multiple biophysical parameters of individual
cells with a suspended microchannel resonator (SMR). First,
to fully understand how cells respond to osmotic stress, we
measured volume, density, and passage time through a
narrow constriction. Increasing the media osmolarity led
to increased density and decreased volume, as expected.
In contrast to density and volume, passage time is nearly in-
dependent of osmolarity even though deformability changes
considerably, indicating that passage time should be
measured together with cell volume. Finally, we compared
relationships between deformability and density for
cells treated with various pharmacological perturbations,
including latrunculin B, staurosporine, cycloheximide, rapa-
mycin, and Torin 1.Volume (fL)
Fluid density (g/mL)
Buoyant mass
in fluid 2
FIGURE 1 Schematic diagrams of the approaches used to measure
deformability, density, and volume, and examples of the data extracted
from the measurements. (A) An SMR with a constriction measures the
passage time and buoyant mass as a cell flows into an embedded mi-
crofluidic channel and transits through the constriction. (B) Passage
time versus buoyant mass for the FL5.12 cell line shows the change in
passage time induced by staurosporine (STS). (C) Measuring the buoyant
mass of a single cell in two fluids of different densities allows the cell
density and volume to be determined. (D) Cell density versus volume
of FL5.12 cells treated with STS. Treatment with STS leads to an increase
in density and a slight decrease in volume. To see this figure in color,
go online.MATERIALS AND METHODS
Cell culture and preparation
FL5.12 cells, a murine pro-B lymphoid cell line, were cultured as previ-
ously described (24). Briefly, cells were cultured in RPMI media (Invitro-
gen, Grand Island, NY) supplemented with 10% (v/v) fetal bovine serum
(Sigma-Aldrich, St. Louis, MO), 100 IU penicillin, 100 mg/mL strepto-
mycin (Gemini, West Sacramento, CA), and 0.02 mg/mL IL-3 (R&D
Systems, Minneapolis, MN) at 37C. FL5.12 cells were exposed to an
osmotic challenge or biochemical agent before each measurement. To
maintain each condition during the experiment, the media used in the
SMR were also supplemented with the same stimuli. For the osmotic
challenge, cells were collected from the culture flask, centrifuged at
150 g for 5 min, resuspended in hypertonic or hypotonic media, and incu-
bated for 30 min before each measurement. D-mannitol (182.17 g/mol;
Sigma-Aldrich) and deionized H2O (dH2O) were added to the media
for the hyperosmotic and hypoosmotic conditions, respectively. For the
isoosmotic control group (300 mOsm/L), cells were resuspended in the
untreated culture medium. For chemical perturbations, cells were resus-
pended and incubated in the media supplemented with 5 mg/mL latruncu-
lin B for 30 min (Sigma-Aldrich), 2 mM staurosporine for 2 h (Enzo Life
Sciences, Farmingdale, NY), 1 mg/mL or 10 mg/mL cycloheximide for 3 h
(Sigma-Aldrich), 100 nM rapamycin (Santa Cruz Biotechnology, Dallas,
TX) for 24 h, or 250 nM Torin 1 for 24 h (generously provided by Prof.
David M. Sabatini, Massachusetts Institute of Technology). The control
groups for these conditions were cells resuspended in the culture media
supplemented with DMSO as the vehicle. The SMR data acquired at
the start of the measurement were compared with those acquired
at the end of the measurement to ensure that the data showed no time
dependence.Experimental systems
SMRs were fabricated at Innovative Micro Technology (Santa Barbara,
CA). The overall instrumentation used for measurement and data acquisi-
tion was previously described in detail (25). Schematics of the experi-
mental approaches are shown in Fig. 1. One SMR system was used to
measure density and volume, and a separate SMR system was used
to measure passage time. To measure density and volume, each cell was
weighed in the SMR in two fluids as previously described (12). Briefly,
a cell immersed in a fluid of low density (fluid 1, ~1.01 g/mL) was flowed
from a bypass channel through a channel embedded in a resonatingBiophysical Journal 109(8) 1565–1573cantilever, and trapped in an opposite bypass filled with a fluid of high
density (~1.1 g/mL). The direction of flow was reversed and the same
cell was passed through the cantilever a second time, but now in fluid 2
(~1.08 g/mL, a mixture of the high-density fluid and a residual amount
of fluid 1). Each time the cell flowed through the cantilever, a buoyant
mass measurement was recorded along with a corresponding fluid density
value. The two buoyant masses were plotted versus their respective fluid
densities to obtain a line with a slope corresponding to cell volume and
an x-intercept corresponding to cell density (Fig. 1 C). As the value of
cell density approached that of the fluid density, the cell buoyant mass
became progressively smaller and thus more difficult to accurately deter-
mine. Therefore, using our current system, we were unable to quantify
the density of cells that were exposed to very high osmotic stresses
(>500 mOsm/L), since the value of the cell density approached that of
the fluid 2 density. For all density measurements, a 7:3 mixture of cell
media/iodixanol solution (OptiPrep Density Gradient Medium; Sigma-
Aldrich) was used as the high-density fluid. In experiments involving
osmotic stress, the osmolarity of this solution was adjusted with either
mannitol or water to match that of fluid 1.
To measure passage time, single cells were measured in an SMR with
a constriction as previously described (23). Briefly, in this approach, a
cell is flowed into the embedded microfluidic channel of the SMR and
is deformed as it flows into the constriction. The constriction consists
of a rectangular channel 6 mm wide, 15 mm deep, and 50 mm long. The
cross-sectional area of the constriction is 90 mm2 (6 mm wide  15 mm
deep) and the average diameter of FL5.12 cells is ~12 mm (untreated con-
trol), indicating a maximum cross-sectional area of ~113 mm2. The nar-
row width of the constriction ensures that the cell will deform as it
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Cellular Density, Deformability, and Size 1567squeezes into the constriction’s entrance (entry) and then passes through
the constriction channel (transit). The resonant frequency response of the
SMR, which depends on the cell’s buoyant mass and position in the mi-
crofluidic channel, is tracked in real time as the cell passes through the
channel. The passage time includes the total time required for the cell
to slow down as it deforms to enter the constriction (entry time) and
then to speed up as it travels through and exits the constriction (transit
time). Here, we measured the passage time as a metric for cell deform-
ability, which is defined as the total time required for the cell to deform
to enter and then transit through the constriction. One can estimate the
relative contribution of surface friction to the passage time by comparing
the cell’s velocities during entry (entry velocity) and transit (transit veloc-
ity). Typically, the passage time is dominated by the entry time because
the transit velocity is significantly faster than the entry velocity (23).
We consistently observed dominance of the passage time by the entry
time in a previous study (23) in which we measured seven adherent
cell lines, including mouse embryonic fibroblasts, mouse lung cancer
cell lines, and human lung cancer cell lines, as well as a mouse lympho-
blastic leukemia cell line that was grown in suspension. We also
measured cells in various conditions obtained, for example, by treating
cells with latrunculin B or nocodazole, or coating the microchannel sur-
face with positively charged poly-L-lysine. In all of these cell lines and
treatments, the passage time was dominated by the entry time (23).
Therefore, here we assume that friction can affect, but does not dominate,
the differences in passage times. The fluidic channel was coated with
poly(ethylene glycol) (1 mg/mL; PLL(20)-g[3.5]-PEG(2); Surface Tech-
nology) to reduce nonspecific adhesion of cells to the walls of the
constriction. All measurements were acquired at room temperature under
a constant applied pressure drop across the microchannel (0.15 psi) estab-
lished by pressure regulators.250 300 350 400 500
Osmolarity (mOsm/L)
FIGURE 2 Effect of osmotic stress on density and volume. FL5.12 cells
are incubated in hypo- and hyperosmolar media for 30 min before and
during the measurement. (A) Boxplots of density from a representative
experiment. Each data point represents the density of an individual cell
(n ¼ 83–170). (B) Density changes resulting from osmotic stress across
multiple replicates. A single point represents the geometric mean of one
replicate and the green line indicates the mean from multiple replicates
(n ¼ 3–8 for each condition). (C) Boxplots of volume from a representa-
tive experiment. The data shown were measured simultaneously with
density in (A). Each data point represents the volume of an individual
cell. (D) Volume changes resulting from osmotic stress across multiple
replicates. A single point represents the geometric mean of one replicate
and the green line indicates the mean from all replicates (n ¼ 3–8 for
each condition). (E) Changes in cellular water content resulting from
osmotic stress across multiple replicates. A single point represents the
geometric mean of one replicate, and the green line indicates the mean
from all replicates (n ¼ 3–8 for each condition). To see this figure in co-
lor, go online.Data analysis
We converted the SMR frequency data to buoyant mass, passage time, vol-
ume, and density using previously described methods (12,23). The data
plotted in Figs. 2, C–E, and 3, A and C, represent volume, water content,
passage time, and buoyant mass, respectively. These parameters are plotted
with a logarithmic scale, which we consider to be the form that most accu-
rately represents the data. Cell size follows a log-normal distribution, as
previously reported (26). Passage time is expected to follow a log-normal
distribution as well, since passage time has a strong power-law dependence
on buoyant mass, as shown in Fig. 1 B (23,27).
As noted in previous studies (12,23,25), the SMR can be used to measure
biophysical properties with high precision. The buoyant mass and the posi-
tion of the center of mass of a particle passing through a constriction in the
SMR can be measured with a precision near 1 pg and submicron, respec-
tively (23). Additionally, the density and volume can be measured with a
resolution of 0.001 g/mL and 3 fL, respectively (12). We can therefore attri-
bute the variability observed in our measurements to inherent biological
variations rather than experimental artifacts. For example, one source of
a biological variation in size is related to the distribution of cells across
the cell cycle. Interestingly, in our measurements, cells of similar buoyant
mass showed a significant variation in passage time (Fig. 1 B), suggesting
that in addition to a biological variation, such as in the cell cycle (10), the
orientation of the cell upon entry into the constriction can cause a wide dis-
tribution (23,28).
The buoyant mass obtained during passage-time measurements was con-
verted to volume using the following equation:
V ¼ bm
rcell  rfluid
;
where V is the cell volume, bm is the cell buoyant mass, rcell is
the average cell density obtained from a corresponding SMR densitymeasurement, and rfluid is the fluid density. The uncertainty that
was contributed to the volume distribution by converting the buoyant
mass using an average cell density was determined to be not signif-
icant based on a Monte Carlo estimate (Fig. S1 in the Supporting
Material).
Statistically significant differences between density measurements were
determined using a nonparametric rank-sum analysis (Wilcoxon rank sum)
implemented in MATLAB (The MathWorks, Natick, MA). Changes in pas-
sage time were estimated and the statistical significance of those changes
was tested by fitting data sets to a linear model in R. For all statistical tests,
a p-value% 0.05 was considered significant. In particular, since most sta-
tistical tests showed very small p-values (1050–105), we indicated those
small p-values by p < 0.0001.Biophysical Journal 109(8) 1565–1573
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FIGURE 3 Effect of osmotic stress on passage time and buoyant mass.
FL5.12 cells were incubated in hypo- and hyperosmolar media for
30 min before and during the measurement. Passage time and buoyant
mass were relatively unaffected by osmotic stress at 250, 350, and 400
mOsm/L. (A) Boxplots of passage time scaled by the median of the control
(300 mOsm/L). Each data point represents the passage time of an individual
cell (n ¼ 972–1101). (B) Percentage change in the median passage time.
The median passage time from each condition is normalized by the median
of the control. A single point represents one replicate and the green line in-
dicates the mean from multiple replicates (n ¼ 3–6 for each condition). (C)
Boxplots of buoyant mass scaled by the median of the control. The data
shown were measured simultaneously with passage time in (A). Each
data point represents the buoyant mass of an individual cell. (D) Percentage
change in the median buoyant mass. The median buoyant mass from each
condition is normalized by the median of the control. A single point repre-
sents one replicate and the green line indicates the mean from multiple rep-
licates (n ¼ 3–6 for each condition). To see this figure in color, go online.
1568 Byun et al.RESULTS AND DISCUSSION
Characterizing the density and volume of cells
exposed to osmotic stress
To characterize the biophysical effects of osmotic stress, we
first measured changes in the density and volume of FL5.12
cells exposed to a range of osmolarities (Fig. 2). We varied
the osmolarity of the cell medium from 250 to 600 mOsm/L
by diluting the medium with dH2O or concentrating it with
D-mannitol. Due to limitations described in Materials and
Methods, we were not able to measure the density and vol-
ume at 600 mOsm/L, although we did obtain passage time
measurements. Cell density increased after exposure to
hyperosmotic media and decreased after exposure to hypo-
osmotic media (Fig. 2 A), whereas the effect of osmotic
stress on cell volume showed the opposite trend (Fig. 2
B). We expect that the primary source of this trend is the
change in cellular water content (29,30). Water has a lower
density than most nonaqueous cellular components, particu-
larly proteins, nucleic acids, and certain lipid conjugates
(31–33). Thus, when an osmotic challenge leads to a changeBiophysical Journal 109(8) 1565–1573in volume, the ratio of water to nonaqueous components
will change as well. If the cellular water fraction increases,
the density will decrease. This is the case with hypoosmotic
swelling, where the influx of water is associated with both a
larger volume and a lower density. Similarly, the loss of
water in the hyperosmotic case leads to both a decreased
volume and an increased density. We estimated the change
to water content using a previously described method (Sup-
porting Material) and confirmed that hypoosmotic stress
leads to an increase in water content, whereas hyperosmotic
stress leads to a decrease in water content (Fig. 2 E).
Interestingly, cell density appears to have much less vari-
ability compared with volume. We found this to be true both
when we examined a population of cells from a single
measurement (Fig. 2, A and C) and when we compared
the means of multiple measurements (Fig. 2, B and D).
For the 300 mOsm/L measurement shown in the boxplot
in Fig. 2, A and C, the interquartile range of density is
~0.005 g/mL, or ~0.5% of the mean, whereas the interquar-
tile range of volume is ~500 fL, or ~25% of the mean. Simi-
larly, the coefficient of variation (CV) of density is ~0.3%
and that of volume is ~50%. We can attribute the wide vol-
ume range in part to differences in the cell-cycle stage in the
population: the much narrower range of density could sug-
gest that density remains relatively constant for a majority
of the cell cycle. The variability over multiple experiments
is shown in Fig. 2, B and D, where each point represents
the geometric mean of a single measurement, and the green
bar represents the mean across multiple measurements. In
this case, the CVof volume is ~10%, whereas that of density
is 0.065%. This outcome further reinforces the notion that a
biological mechanism maintains the narrow density distri-
bution. As a possible explanation, we can consider density
to be a reflection of the crowding of intracellular macromo-
lecular components. Previous work has shown that the cyto-
plasm is extremely crowded, and that the level of crowding
affects protein stability, adsorption to surfaces, and reaction
rates (34–36). Thus, we can hypothesize that tight regulation
of density results from a requirement to maintain a uniform
level of crowding. An important consequence of the tight
distribution of density relative to volume is that cells of
similar densities will not always have the same volumes.
Thus, simultaneous measurements of both density and vol-
ume are necessary to more accurately describe the cell state.Characterizing the passage time and
deformability of cells exposed to osmotic stress
Next, we determined how osmotic stress affects the passage
of a cell through a narrow constriction by comparing the
median passage times for osmotically stressed cells and an
isoosmotic control. In contrast to cell density and volume,
the effect of an osmotic challenge on passage time was rela-
tively small (Fig. 3). The changes in passage time after os-
motic challenges of 250, 350, and 400 mOsm/L were 0.68%,
Cellular Density, Deformability, and Size 15690.66%, and 5.1%, respectively (Fig. 3 B). However,
increasing the media osmolarity to 500 and 600 mOsm/L re-
sulted in an ~30% increase in passage time. Similarly, after
exposure to osmotic stress, cellular buoyant mass did not
deviate significantly from the control (3.6, 0.79, and
3.6% changes for 250, 350, and 400 mOsm/L, respec-
tively; Fig. 3 D). Exposure to 500 and 600 mOsm/L media
resulted in a further decrease in buoyant mass (9.2% and
16%, respectively), suggesting that buoyant mass de-
creases as osmolarity increases.
The relatively small changes in passage time and buoyant
mass resulting from osmotic stress between 250 and
400 mOsm/L can be attributed to simultaneous, compensa-
tory changes in density and volume. For example, as a cell
is compressed due to an osmotic challenge, its density in-
creases while its volume decreases. As a cell becomes denser
due to water loss, cell deformability decreases by molecular
crowding within cytoplasm (30), which in turn increases the
passage time (23). Therefore, although a denser cell should
exhibit a longer passage time due to its decreased deformabil-
ity (Fig. 4), its smaller volume concurrently decreases the
passage time (23,27). As a result, the overall change in
passage time caused by osmotic stress is relatively small.
These results demonstrate that passage time reported
independently of size may not always predict cell deform-
ability, and that one must compare passage times for cells
of similar size to decouple the effects of varying size and
deformability (23).
Buoyant mass is a convenient size metric because it is
measured simultaneously with passage time for individ-
ual cells (see Fig. 1 and ‘‘Data analysis’’ above). However,
buoyant mass depends on cell volume and density, and,
like passage time, is susceptible to compensatory changesOsmolarity (mOsm/L)Volume (fL)
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FIGURE 4 Determining deformability from passage time by accounting
for cell volume. Volume is obtained by converting single-cell buoyant mass
data using the population average density. (A) Passage time versus volume
from the two data sets (from Fig. 3, isoosmotic and hyperosmotic condi-
tions) in a log-log scale is fitted to the linear models (black lines) with a
fixed slope and variable intercepts corresponding to the two conditions.
The deformability is determined by the ratio of passage times given the
same cell volume, which is acquired from the difference between the two
intercepts (green arrow). (B) Dependence of deformability (percentage
change in passage time based on cell volume) on the osmolarity of the
media. The data used are the same as shown in Fig. 3. To see this figure
in color, go online.in these parameters. Buoyant mass is defined as the product
of the volume and the difference between the cell density
and the density of the surrounding fluid; thus, the increase
in density after osmotic compression would lead to an
increase in buoyant mass, and the decrease in volume
would lead to a decrease in buoyant mass. Indeed, we find
that the buoyant mass remains relatively unaffected by os-
motic compression (350 and 400 mOsm/L; Fig. 3, C and
D). Thus, we define deformability as the passage time of
a cell accounting for its volume, thereby eliminating the
dependence of passage time on size (Fig. 4) (23). By using
an average value for population density, which has a vari-
ance 100-fold smaller than that of both buoyant mass
and volume, we can convert buoyant mass to volume with
only minimal error contributions (Fig. 2, A and C;
Fig. S1) (12,37). This is an improvement over the methods
used in previous studies, in which we performed the same
conversion but started instead with a volume distribution
from a commercial Coulter counter (23,38). A plot of
each data set on a log-log scale is subsequently fit to lines
with a fixed slope and variable intercepts (Fig. 4 A). The
deformability is determined by the ratio of passage times
given the same cell volume, which is acquired from the dif-
ference between the two intercepts (green arrow) and is then
converted to a percentage (Fig. 4 B).
After accounting for volume, we can identify a significant
difference between two cells of the same volume exposed to
different values of media osmolarity (6.1%, 8.5%, and
21% changes for 250, 350, and 400 mOsm/L, respectively),
which demonstrates that cells become stiffer by hyperos-
motic compression and more deformable by hypoosmotic
swelling. In other words, although the population of cells
as a whole still exhibits a passage time similar to that
observed for the isoosmotic control (Fig. 3 B), the viscoelas-
ticity of an individual cell is changed by osmotic stress
(Fig. 4 B). The observed decrease in deformability caused
by hyperosmotic compression and determined by a longer
passage time is consistent with previous studies, one of
which linked the change to cytoplasmic crowding resulting
from water loss (30,39,40). An increase in deformability
due to a hypoosmotic challenge has also been reported
(19,39,41), but is not consistent among all studies (40),
likely due to discrepancies in the measurement techniques
and cell lines used. Our results indicate that one should
take the volume into consideration when relating passage
time through a constriction to cellular deformability.Characterizing cell states by deformability,
density, and volume
When cells are exposed to an osmotic challenge, changes in
density or volume correlate with changes in deformability
due to the dependence of all three parameters on the osmolar-
ity of the surrounding fluid (Fig. 2 A). However, a gen-
eral relationship among density, volume, and deformabilityBiophysical Journal 109(8) 1565–1573
1570 Byun et al.cannot be established a priori, since cellular activity or
external stimuli can affect cellular composition and cyto-
skeletal proteins, which can affect density, volume, and de-
formability independently of each other (1,12). Similarly, a
change involume alone cannot predict density or deformabil-
ity, except when cells change their volume only by water
exchange. Thus, we next sought to investigate representative
relationships of deformability versus density and volume
(Fig. 5), which would allow us to demonstrate how cell states
can be characterized by multiple biophysical properties. InLatB
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FIGURE 5 Deformability versus density and volume for various condi-
tions: osmotic challenge (250, 350, 400, and 500 mOsm/L), latrunculin B
(LatB), staurosporine (STS), 1 mg/mL and 10 mg/mL of cycloheximide
(CHX), rapamycin (Rap), and Torin 1 (Tor). Changes in deformability, den-
sity, and volume after treatments are quantified based on the isoosmotic
control (untreated, 300 mOsm/L) in each experiment. Plots are divided
into four quadrants, defined by two gray dotted lines. (A) The percentage
change in passage time accounting for volume is plotted versus the change
in density. The correlation between changes in deformability and density
depends on the mechanism associated with each treatment. (B) The percent-
age change in passage time accounting for volume is plotted versus the
change in volume. Rap, Tor, and CHX (1 mg/mL) are located in different
quadrants compared with (A) (arrows). Vertical error bars represent the
standard deviation of the mean. Horizontal error bars (density and volume)
represent the standard error of the mean. All treatments induce a significant
change in density (p < 0.0001, Wilcoxon rank sum). All treatments, except
Torin 1 (p ¼ 0.0501), induce a significant change in passage time (p <
0.0001, linear model). The data for the osmotic challenge are the same as
those shown in Fig. 4. For the other conditions, we measured ~200 cells
and ~1000 cells for density and deformability, respectively. To see this
figure in color, go online.
Biophysical Journal 109(8) 1565–1573addition to an osmotic challenge, FL5.12 cells were exposed
to the following conditions: latrunculin B, staurosporine,
cycloheximide (1 mg/mL or 10 mg/mL), rapamycin, and
Torin 1. A summary of the effects of these drugs is provided
in Table S1. Density, volume, and deformability were
measured using the same methods as previously described.
Passage time accounting for volume was then plotted versus
density (Fig. 5 A) and volume (Fig. 5 B).
Increases in osmolarity led to increases in density and
decreases in volume and deformability, represented by the
black solid lines in Fig. 5, A and B. Latrunculin B, however,
led to an increase in deformability accompanied by a slight
increase in density and an insignificant change in volume
(Fig. 5, A and B, green line). A small increase in volume
by latrunculin B was previously reported (42). This outcome
likely results from the relatively specific behavior of latrun-
culin B, which complexes with actin monomers to inhibit
actin polymerization (43). These changes may result in a
slight change in cellular water content due to shifting hydra-
tion layers in the proteins, which may be sufficient to change
density, but not volume (44).
Treatment with staurosporine (Fig. 5, A and B, red line)
maintained the same relationship between density and
deformability as we observed with osmotic stress, but
with a greater change in deformability. A cell undergoing
apoptosis by staurosporine typically shows an apoptotic vol-
ume decrease and denser cytoplasm, which is consistent
with our measurements of volume and density (45). Stauro-
sporine can also lead to cell-cycle arrest (46), inhibit protein
synthesis independently of caspase activation (47), and
delocalize myosin II (48). Therefore, a decrease in deform-
ability after staurosporine treatment may be related to
impaired myosin activity, which may explain why stauro-
sporine leads to a much greater change in deformability
than does hyperosmotic compression.
Treatment with 10 mg/mL of cycloheximide decreased
density similarly to what we observed under a hypoosmotic
condition (250 mOsm/L), but resulted in a greater increase
in deformability. The increase in deformability caused by
cycloheximide treatment, which inhibits protein synthesis,
is consistent with a previous study (49). Interestingly, the
biological effects of cycloheximide depend on the concen-
tration and cell type used. For example, although cyclohex-
imide is cytotoxic at low concentrations to Jurkat cells, it
has no effect on CEMC7 cells at low or high concentrations,
even though both are human leukemic cell lines (50). More-
over, studies of different cell types exposed to low levels of
cycloheximide have shown that it may have cytoprotective
effects (51). This concentration dependence may explain
the slight discrepancy between the changes in density and
volume observed with 1 mg/mL and 10 mg/mL of cyclohex-
imide (Fig. 5, A and B, arrows). Since cycloheximide can
also induce elongation or arrest of the cell cycle, which
may affect the protein content and cell volume (52,53),
the relationship between volume and density is difficult to
Cellular Density, Deformability, and Size 1571predict. Thus, although density and volume are inversely
correlated at the higher concentration, they are directly
correlated at the lower concentration.
Similarly to the case with cycloheximide, we also
noticed that Torin 1 and rapamycin induced decreases in
both density and volume, providing another example of
how volume is not always inversely related to density (ar-
rows in Fig. 5 B). This outcome may be attributed to the
biological effect of Torin 1 and rapamycin, which block
mTOR, leading to cell-cycle arrest at the G1/S transition
and inhibiting protein synthesis (54,55). Previous studies
have shown that cell volume and deformability depend on
cell cycle stage (10). The slight decrease in population vol-
ume may thus be attributed to arrest in S phase. A decrease
in density could be due to lower levels of both protein and
DNA. In addition, Torin 1 and rapamycin are also known to
affect actin polymerization and protein synthesis (56–59).
Previous studies have demonstrated that Torin 1 and rapa-
mycin can inhibit actin polymerization (57); however, rapa-
mycin can also increase actin polymerization in RBL-2H3
cells (56), suggesting that the slight decrease in cell de-
formability by these mTOR inhibitors may be induced by
the change in actin structure.
Wewould also like to note that the drugs used in our study
typically cause a more significant change in deformability
than does osmotic stress. For example, staurosporine induces
a >200% change in passage time, and the deformability of
FL5.12 cells is increased by cycloheximide regardless of
changes in density or volume. This suggests that the integrity
of the cytoskeletal structure can play amore important role in
deciding deformability than the changes driven by water ex-
change. However, Zhou et al. (30) previously showed that a
latrunculin A-induced weakening of cytoskeletal rigidity
was overwhelmed by a stiffening of the cytoplasm induced
by very high osmotic stress (~1000 mOsm/L), suggesting
that a change in the cytoskeletal structure does not always
dominate cell deformability.CONCLUSIONS
We have shown the value of measuring multiple biophys-
ical parameters concurrently. Although volume is the most
commonly identifiable cell-size metric, density can reveal
additional information for understanding the mechanical
properties of cells. Density may represent changes in struc-
ture or composition, as well as the crowdedness in the cyto-
plasm, which may not be directly related to volume but may
still affect deformability. Grover et al. (12) previously found
that measurements of density enable the identification of
cell states that are not detectable by other cell-size metrics,
such as volume and mass. However, changes in deformabil-
ity may not necessarily lead to changes in any size metric,
particularly if the deformability change is associated with
changes in structural proteins. Thus, by combining measure-
ments of deformability and density, we can detect morespecific biophysical characteristics that refine our represen-
tation of the cell state.SUPPORTING MATERIAL
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